- Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
-
Tan DS, Chan JJ, Hettle R, Ghosh W, Viswambaram A, Yu CC
- KMID: 2526375
- J Gynecol Oncol.
- 2021 Mar;32(2):e27.
- doi: 10.3802/jgo.2021.32.e27
Objective: To evaluate the cost-effectiveness of olaparib as a maintenance treatment versus routine surveillance (RS) in patients with BRCA mutated (BRCAm) advanced ovarian cancer (OC) following response to first-line platinum-based... -
- CITED
-
- Close
- SHARE
-
- Close
- Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories
-
Ithimakin S, Parinyanitikul N, Kim SB, Yap YS, Tsang J, Soong IS, Ozaki Y, Ohno S, Ono M, Chan JJ, Cheng HCS, Dejthevaporn T, on behalf of BIG-Asia Collaboration
- KMID: 2530764
- J Breast Cancer.
- 2022 Jun;25(3):207-217.
- doi: 10.4048/jbc.2022.25.e21
Purpose: Breast cancer (BC) treatment has shifted from chemotherapy to targeted therapy. Several targeted agents have demonstrated an improvement in survival. Given that national healthcare resources were correlated with the cancer... -
- CITED
-
- Close
- SHARE
-
- Close
